Key Developments For Genetic Technologies Limited
Genetic Technologies Limited (GENE.O) (Consolidated Issue listed on NASDAQ Global Market)
Genetic Technologies Limited Announces Resignation of Mr. Fred Bart As Chairman
The Board of Directors of Genetic Technologies Limited announced that the Company’s Chairman, Mr. Fred Bart, has resigned as a Director of the Company and various subsidiaries. As a result, Resolution 2 of the Notice for the 2009 Annual General Meeting, which was to consider Mr. Bart’s re-election, has been withdrawn and will therefore not be put before the Meeting which is scheduled to be held.
Rosetta Genomics, Ltd. Names Genetic Technologies Limited As Exclusive Distributor For microRNA Based Assays In Australia, New Zealand And Singapore
Rosetta Genomics, Ltd. and Genetic Technologies Limited announced the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests. Under the terms of the agreement, the Company will market Rosetta Genomics' miRview tests in Australia, New Zealand and Singapore. Further financial terms were not disclosed.
Genetic Technologies Limited Appoints Paul MacLeman As CEO
Genetic Technologies Limited announced that it has appointed Dr. Paul MacLeman as its new Chief Executive Officer (CEO). Dr. MacLeman is due to take up his position on May 4, 2009.
Genetic Technologies Limited Comments On Long Term Revenue Outlook
Genetic Technologies Limited announced that constant revenue growth of 18% is assumed beyond fiscal 2009 based on the historical five-year average growth rate applicable to the testing business.
Regis Resources Limited Announces Purchase Of North Laverton Joint Venture Minority Interest From Genetic Technologies Limited
Regis Resources Limited announced that is has reached agreement with Genetic Technologies Limited, to purchase the Companies 14.66% interest in the North Laverton Joint Venture (NLJV) in the Duketon region, north of Laverton, Weston Australia. Regis and its subsidiaries own the remaining 85.34% and are managers of the NLJV.
